The role of magnetic resonance spectroscopy in the assessment of kidney viability

Scandinavian Journal of Urology and Nephrology

Volumn 31, Issue 5, 1997, Pages 487-492

  Barnard, Maria L ^a   Changani, K Kumar ^a,b   Taylor Robinson, Simon D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Kidney viability; Magnetic resonance spectroscopy; Renal transplantation

Indexed keywords

ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROMETRY;

EID: 0030730175     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599709030648     Document Type: Article

References (33)

1. 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Ada 1993; 1225: 71-77.
2. Beizer FO. Evaluation of preservation of the intraabdominal organs. Transplant Proc 1993; 25: 2527-2530.
3. Bloch F, Hansen WW, Packard ME. Nuclear induction. Physics Rev 1946; 69: 127.
4. Bretan PN, Vigneron DB, James TL, Williams RD, Hricak H, Juenemann KP, Yen TS, Tanagho EA. Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. J Urol 1986; 135: 866-871.
5. Bretan PN, Vigneron DB, Hricak H, Juenemann KP, Williams RD, Tanagho EA, James TL. Assessment of renal preservation by phosphorus-31 magnetic resonance spectroscopy: in vivo normothermic blood perfusion. J Urol 1986; 136: 1356-1359.
6. Bretan PN, Vigneron DB, Hricak H, Collins GM, Price DC, Tanagho EA. Assessment of clinical renal preservation by phosphorus-31 magnetic resonance spectroscopy. J Urol 1987; 137: 146-150.
7. Bretan PN, Baldwin N, Novick AC, Majors A, Easley K, Ng T, et al. Pretransplantation assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy. Transplantation 1989; 48: 48-53.
8. Bretan PN, Baldwin N, Martinez A, Stowe N, Scarpa A, Easley K, et al. Improved renal transplant preservation using a modified intracellular flush solution (PB-2). Characterisation of mechanisms by renal clearance, high performance liquid chromatography, phosphorus-31 magnetic resonance spectroscopy, and electron microscopy studies. Urol Res 1991; 19: 73-80.
9. 31P-NMR study. Transplantation 1996; 62: 787-793.
10. 31P NMR study in pig liver. J Hepatol 1997; 26: 336-342.
11. Ciancabilla FG, Pincemail JF, Defraigne J-O, Franssen CL, Carlier PG. The effect of technical conditions and storage medium composition on the phosphomonoesters to inorganic phosphate ratio determined by P nuclear magnetic resonance spectroscopy in rabbit kidney. Transplantation 1993; 56: 696-699.
12. Cohen RD, Henderson RM, Iles RA, Monson JP, Smith JA. Metabolic acidosis. In: Ciba Foundation Symposium 84, Pitman, London, 1982: 20.
13. 31P magnetic resonance of the normal liver: towards in vivo biochemical pathology. Clin Sci 1992; 83: 183-190.
14. 31P NMR studies of intracellular free magnesium in the intact frog skeletal muscle. J Biol Chem 1980; 256: 3987-3993.
15. 31P magnetic resonance spectroscopy. Kidney Int 1994; 46: 1694-1699.
16. Henze E, Lietzenmayer R, Kunz R, Schnur G, Clausen M, Schoser K, et al. Prerequisites and initial experience for the non-invasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy. Transplant Proc 1990; 22: 2404-2408.
17. Iles RA, Griffiths JR, Stevens AN. Perturbations in hepatic energy metabolism. Biochem Soc Trans 1985; 13: 843-845.
18. Kootstra G, Wijnen R, van Hooff JP, van der Linden CJ. Twenty percent more kidneys through a non-heart-beating program. Transplant Proc 1991; 23: 910-911.
19. 31P NMR. Transplant Proc 1989; 21: 1269-1271.
20. Nicholson M. Kidney transplantation from asystolic donors. Br J Hosp Med 1996; 55: 51-56.
21. Nielsen MS. Elective ventilation. J Roy Coll Phys Lond 1994; 28: 85.
22. Ploeg RJ, van Bocket JH, Langendiijk PTH, Groenewegen M, van der Woude FJ, Persijn GG, et al. Effect of preservation solution on results of cadaveric kidney transplantation. European Multicentre Study Group. Lancet 1992; 340: 129-137.
23. Purcell EM, Torrey HC, Pound RV. Resonance absorption by nuclear magnetic moments in a solid. Phys Rev 1946; 69: 37-38.
24. Radda GK, Rajagopalan B, Taylor DJ. Biochemistry in vivo: an appraisal of clinical magnetic resonance spectroscopy. Magn Reson Q 1989; 5: 122-151.
25. Riad H, Nicholls A, Neuberger J, Willatts SM, Sells RA, Jones MA, Francis R. Elective ventilation of potential organ donors. Br Med J 1995; 310: 714-718.
26. 31P NMR. New Engl J Med 1981; 304: 1338-1342.
27. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed 1992; 5: 226-233.
28. Sehr PA, Radda GK. A model kidney transplant studied by phosphorus nuclear magnetic resonance. Biochem Biophys Res Commun 1977; 77: 195-202.
29. 31P nuclear magnetic resonance. Br J Exp Pathol 1979; 60: 632-641.
30. 31P nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77-94.
31. United Kingdom Transplant Support Services Authority. Yearly Transplant Statistics. UKTSSA, Bristol, 1996.
32. Varty K, Veitch PS, Morgan JDT, Kehinde EO, Donnelly PK, Bell PRF. Response to organ shortage: kidney retrieval programme using non-heart beating donors. Br Med J 1994; 308: 575.
33. Wing AJ, Chung RWS. Non-heart beating donors as a source of kidneys. Br Med J 1994; 308: 549-550.